Bank of Hawaii Grows Stock Holdings in Danaher Co. (NYSE:DHR)

Bank of Hawaii lifted its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 23.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,348 shares of the conglomerate’s stock after acquiring an additional 2,763 shares during the quarter. Bank of Hawaii’s holdings in Danaher were worth $3,989,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Douglass Winthrop Advisors LLC increased its holdings in Danaher by 3.1% during the 3rd quarter. Douglass Winthrop Advisors LLC now owns 76,095 shares of the conglomerate’s stock worth $21,156,000 after purchasing an additional 2,256 shares during the period. Fisher Asset Management LLC grew its position in shares of Danaher by 2.6% during the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock worth $1,265,725,000 after buying an additional 116,299 shares in the last quarter. Daiwa Securities Group Inc. increased its stake in shares of Danaher by 2.1% during the third quarter. Daiwa Securities Group Inc. now owns 98,024 shares of the conglomerate’s stock valued at $27,253,000 after buying an additional 2,052 shares during the period. Hartford Funds Management Co LLC lifted its stake in Danaher by 4.5% in the third quarter. Hartford Funds Management Co LLC now owns 1,794 shares of the conglomerate’s stock worth $499,000 after acquiring an additional 77 shares during the period. Finally, Summit Trail Advisors LLC grew its holdings in Danaher by 5.1% during the 3rd quarter. Summit Trail Advisors LLC now owns 11,426 shares of the conglomerate’s stock worth $3,180,000 after acquiring an additional 555 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on DHR shares. KeyCorp boosted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Raymond James lowered their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Stifel Nicolaus lifted their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. TD Cowen upped their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada cut their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $287.16.

View Our Latest Analysis on DHR

Danaher Price Performance

Shares of DHR opened at $235.84 on Monday. The firm has a market capitalization of $170.34 billion, a PE ratio of 45.01, a price-to-earnings-growth ratio of 4.34 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company’s fifty day moving average price is $258.15 and its 200-day moving average price is $260.03. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 EPS. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities research analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher’s payout ratio is 20.61%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.